Ricky Hopson - 31 Aug 2022 Form 4 Insider Report for Catalent, Inc.

Role
Pres. Clinical Dev Supply Div
Signature
/s/ Amy Fallone, attorney-in-fact
Issuer symbol
N/A
Transactions as of
31 Aug 2022
Net transactions value
-$198,531
Form type
4
Filing time
02 Sep 2022, 14:43:16 UTC
Previous filing
26 Aug 2022
Next filing
25 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTLT Common Stock Sale $198,531 -2,216 -11% $89.59 17,095 31 Aug 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
F2 Includes restricted stock units.